Sorry, you need to enable JavaScript to visit this website.

A Placebo Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects

A Placebo Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects.  A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata

Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06651600
ClinicalTrials.gov Identifier (NCT): NCT03732807
Protocol ID: B7981015
    Share
PrintDownload
Open Plain Language Summary Result: Click here